AJANTA PHARMA LTD. - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
02 Feb 2017
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Madhusudan B Agrawal
Source:
BSE India